Arvinas, Inc.
(ARVN - NASDAQ)
10,29 USD
📋 Profilo Aziendale

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

|